Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

49.71
Delayed Data
As of Aug 22
 +0.83 / +1.70%
Today’s Change
37.38
Today|||52-Week Range
51.13
+29.42%
Year-to-Date

Today’s Trading

Previous close48.88
Today’s open48.95
Day’s range48.88 - 49.85
Volume4,018,805
Average volume (3 months)6,218,823
Market cap$84.9B
Dividend yield2.13%
Data as of 4:01pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.31%
Earnings growth (next 5 years)+11.30%
Revenue growth (last year)+2.20%
P/E ratio77.7
Price/Sales2.73
Price/Book3.51

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.88+1.14%
NVONovo Nordisk+0.69+1.52%
BMYBristol-Myers Squibb+1.03+1.82%
GSKGlaxoSmithKline+0.45+1.16%
Data as of 4:03pm ET, 08/22/2017

Financials

Next reporting dateOctober 18, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts